{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:53:43Z","timestamp":1792079623548,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Primary intraosseous vascular malformation (VMPI, #606893) is an ultra-rare disorder caused by biallelic pathogenic variants in\n                    <jats:italic>ELMO2<\/jats:italic>\n                    . To date, only six families with pathogenic\n                    <jats:italic>ELMO2<\/jats:italic>\n                    variants causing a VMPI phenotype have been described. VMPI is characterized by vascular malformations that compress the facial bones, often leading to life-threatening complications, such as massive bleeding and intracranial herniation. In VMPI, vascular malformations are progressive and there is no causal therapy available. We report on four unreported individuals with classical VMPI harbouring biallelic truncating variants in\n                    <jats:italic>ELMO2<\/jats:italic>\n                    , including a novel homozygous 25\u2009bp duplication c.579_603dup; p.(Leu202Profs*47), detected by whole-exome sequencing. We present extensive clinical follow-up data, including a close monitoring of an individual from prenatal diagnosis onwards. Using computed tomography or magnetic resonance imaging angiography, we described the radiological characteristics of vascular malformations with fast-flow properties in the affected individuals. Additionally, we conducted a comprehensive histopathological evaluation of samples from one individual. This analysis revealed not only the similar morphological features described previously but also some atypical findings, such as increased de novo bone formation. Furthermore, we report for the first time the use of propranolol and sirolimus in VMPI. While we noted a reduction of bleeding episodes in one individual, no significant clinical improvement was observed overall in the other individuals treated with sirolimus. Moreover, sirolimus led to severe infectious complications with abscess formation in two individuals. Conversely, propranolol was relatively well tolerated, although it did not result in any notable clinical outcomes. During follow-up, one individual died due to severe bleeding.\n                  <\/jats:p>","DOI":"10.1038\/s41431-024-01739-z","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T08:01:01Z","timestamp":1733212861000},"page":"334-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ELMO2-related intraosseous vascular malformation: new cases with novel pathogenic variants, clinical follow-up and therapeutic approaches"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-8894","authenticated-orcid":false,"given":"Mert","family":"Karakaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5848-8294","authenticated-orcid":false,"given":"Iman","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2276-9983","authenticated-orcid":false,"given":"Vera","family":"Riehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2768-1702","authenticated-orcid":false,"given":"Florian","family":"Erger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal Hussien","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Woo","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go Hun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-7973","authenticated-orcid":false,"given":"Marc","family":"Hoemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Maria","family":"Schultheis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1607-0543","authenticated-orcid":false,"given":"Boris","family":"Decarolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"1739_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.sempedsurg.2014.06.016","volume":"23","author":"R Dasgupta","year":"2014","unstructured":"Dasgupta R, Fishman SJ. ISSVA classification. Semin Pediatr Surg. 2014;23:158\u201361.","journal-title":"Semin Pediatr Surg"},{"key":"1739_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ajmg.10282","volume":"109","author":"I Vargel","year":"2002","unstructured":"Vargel I, Cil BE, Er N, Ruacan S, Akarsu AN, Erk Y. Hereditary intraosseous vascular malformation of the craniofacial region: an apparently novel disorder. Am J Med Genet. 2002;109:22\u201335.","journal-title":"Am J Med Genet"},{"key":"1739_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ajhg.2016.06.008","volume":"99","author":"A Cetinkaya","year":"2016","unstructured":"Cetinkaya A, Xiong JR, Vargel I, Kosemehmetoglu K, Canter HI, Gerdan OF, et al. Loss-of-Function Mutations in ELMO2 Cause Intraosseous Vascular Malformation by Impeding RAC1 Signaling. Am J Hum Genet. 2016;99:299\u2013317.","journal-title":"Am J Hum Genet"},{"key":"1739_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/SAP.0000000000001786","volume":"83","author":"I Vargel","year":"2019","unstructured":"Vargel I, Calis M, Canter HI, Cil BE. Clinical and Molecular Study of ELMO-2-Related Massive Intraosseous Vascular Malformations: Lessons Learned From 25 Years of Follow-up. Ann Plast Surg. 2019;83:293\u20139.","journal-title":"Ann Plast Surg"},{"key":"1739_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41431-018-0195-2","volume":"26","author":"F Erger","year":"2018","unstructured":"Erger F, Burau K, Elsasser M, Zimmermann K, Moog U, Netzer C. Uniparental isodisomy as a cause of recessive Mendelian disease: a diagnostic pitfall with a quick and easy solution in medium\/large NGS analyses. Eur J Hum Genet. 2018;26:1392\u20135.","journal-title":"Eur J Hum Genet"},{"key":"1739_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/cge.13848","volume":"98","author":"GH Seo","year":"2020","unstructured":"Seo GH, Kim T, Choi IH, Park JY, Lee J, Kim S, et al. Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE. Clin Genet. 2020;98:562\u201370.","journal-title":"Clin Genet"},{"key":"1739_CR7","doi-asserted-by":"publisher","first-page":"Suppl:73","DOI":"10.1007\/BF00543714","volume":"28","author":"A Westerlund","year":"1985","unstructured":"Westerlund A. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers. Eur J Clin Pharm. 1985;28:Suppl:73\u20136.","journal-title":"Eur J Clin Pharm"},{"key":"1739_CR8","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1634\/theoncologist.2009-0115","volume":"14","author":"PK Palaska","year":"2009","unstructured":"Palaska PK, Cartsos V, Zavras AI. Bisphosphonates and time to osteonecrosis development. Oncologist. 2009;14:1154\u201366.","journal-title":"Oncologist"},{"key":"1739_CR9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Bick D, Das S, Grody W, Spector E, Gastier-Foster J, et al. Interpreting sequence variants in a clinical context Response. Genet Med. 2015;17:1013\u20134.","journal-title":"Genet Med"},{"key":"1739_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/cge.13166","volume":"93","author":"C Mehawej","year":"2018","unstructured":"Mehawej C, Hoischen A, Farah RA, Marey I, David M, Stora S, et al. Homozygous mutation in ELMO2 may cause Ramon syndrome. Clin Genet. 2018;93:703\u20136.","journal-title":"Clin Genet"},{"key":"1739_CR11","doi-asserted-by":"crossref","unstructured":"Perrone E, Coelho AVC, Virmond LDA, Espolaor JGA, Filho JBO, Nascimento A, et al. ELMO2 biallelic pathogenic variants in a patient with gingival hypertrophy and cherubism phenotype: Case report and molecular review. Am J Med Genet A. 2024;194:e63602.","DOI":"10.1002\/ajmg.a.63602"},{"key":"1739_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0030-4220(67)90416-1","volume":"24","author":"Y Ramon","year":"1967","unstructured":"Ramon Y, Berman W, Bubis JJ. Gingival fibromatosis combined with cherubism. Oral Surg Oral Med Oral Pathol. 1967;24:435\u201348.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"1739_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ajmg.1320250305","volume":"25","author":"JM Pina-Neto","year":"1986","unstructured":"Pina-Neto JM, Moreno AF, Silva LR, Velludo MA, Petean EB, Ribeiro MV, et al. Cherubism, gingival fibromatosis, epilepsy, and mental deficiency (Ramon syndrome) with juvenile rheumatoid arthritis. Am J Med Genet. 1986;25:433\u201341.","journal-title":"Am J Med Genet"},{"key":"1739_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34806-4","volume":"13","author":"V Tran","year":"2022","unstructured":"Tran V, Nahle S, Robert A, Desanlis I, Killoran R, Ehresmann S, et al. Biasing the conformation of ELMO2 reveals that myoblast fusion can be exploited to improve muscle regeneration. Nat Commun. 2022;13:7077.","journal-title":"Nat Commun"},{"key":"1739_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCRESAHA.121.318145","volume":"129","author":"A Queisser","year":"2021","unstructured":"Queisser A, Seront E, Boon LM, Vikkula M. Genetic Basis and Therapies for Vascular Anomalies. Circ Res. 2021;129:155\u201373.","journal-title":"Circ Res"},{"key":"1739_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s44161-022-00080-2","volume":"1","author":"LM Boon","year":"2022","unstructured":"Boon LM, Dekeuleneer V, Coulie J, Marot L, Bataille A-C, Hammer F, et al. Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformations. Nat Cardiovascular Res. 2022;1:562\u20137.","journal-title":"Nat Cardiovascular Res"},{"key":"1739_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0982-4","volume":"14","author":"E Buscarini","year":"2019","unstructured":"Buscarini E, Botella LM, Geisthoff U, Kjeldsen AD, Mager HJ, Pagella F, et al. Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2019;14:28.","journal-title":"Orphanet J Rare Dis"},{"key":"1739_CR18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12094-015-1389-5","volume":"18","author":"NC Millan","year":"2016","unstructured":"Millan NC, Poveda MJ, Cruz O, Mora J. Safety of bevacizumab in patients younger than 4 years of age. Clin Transl Oncol. 2016;18:464\u20138.","journal-title":"Clin Transl Oncol"},{"key":"1739_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.25100\/cm.v48i2.2719","volume":"48","author":"FE Ospina","year":"2017","unstructured":"Ospina FE, Echeverri A, Posso-Osorio I, Jaimes L, Gutierrez J, Tobon GJ. Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report. Colomb Med (Cali). 2017;48:88\u201393.","journal-title":"Colomb Med (Cali)"},{"key":"1739_CR20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CC 3rd, Hammill AM, Vinks AA, Patel MN, et al. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. Pediatrics. 2016;137:e20153257.","journal-title":"Pediatrics"},{"key":"1739_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0064-x","volume":"9","author":"L di Blasio","year":"2018","unstructured":"di Blasio L, Puliafito A, Gagliardi PA, Comunanza V, Somale D, Chiaverina G, et al. PI3K\/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations. Cell Death Dis. 2018;9:45.","journal-title":"Cell Death Dis"},{"key":"1739_CR22","doi-asserted-by":"crossref","unstructured":"Overman J, Fontaine F, Wylie-Sears J, Moustaqil M, Huang L, Meurer M, et al. R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma. Elife. 2019;8:e43026.","DOI":"10.7554\/eLife.43026"},{"key":"1739_CR23","doi-asserted-by":"crossref","unstructured":"Seebauer CT, Graus MS, Huang L, McCann A, Wylie-Sears J, Fontaine F, et al. Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma. J Clin Investig. 2022;132:e151109.","DOI":"10.1172\/JCI151109"},{"key":"1739_CR24","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1097\/SCS.0000000000004166","volume":"28","author":"JA Goss","year":"2017","unstructured":"Goss JA, Konczyk DJ, Alomari MH, Maclellan RA, Greene AK. Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma. J Craniofac Surg. 2017;28:2001\u20133.","journal-title":"J Craniofac Surg"}],"updated-by":[{"DOI":"10.1038\/s41431-025-01965-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000}}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01739-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:03:18Z","timestamp":1764180198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01739-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1038\/s41431-024-01739-z","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41431-025-01965-z","URL":"https:\/\/doi.org\/10.1038\/s41431-025-01965-z","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All investigations were conducted in adherence with the principles of the Declaration of Helsinki. Written informed consent for genetic testing and for publishing individual photographs, genetic and clinical data, including radiological images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}